Announce Date | 08/27/2025 |
EPS Normalized Actual | $-0.27 (Miss by $-0.32) |
EPS GAAP Actual | $-0.27 (Miss by $-0.32) |
Revenue Actual | $1.857B |
Revenue Surprise | Beat by $1857M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Feb 2028 | 3.61 | 6.65 | 3.5222 | 3.68304 | 0 |
Feb 2028 | 2.05947 | 11.66 | 2.009 | 2.09522 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2025 (Jul 2025) | 0 | 0 | 1.857B | 100% | 1857M |
FQ2 2025 (May 2025) | -3.81 | -3.81 | 1.794B | 100% | 1794M |
FQ1 2025 (Feb 2025) | 0.64 | 0.64 | 2.248B | 100% | 2248M |
FQ4 2024 (Nov 2024) | -0.35 | -0.35 | 1.961B | 100% | 1961M |
FQ3 2023 (Jul 2023) | -0.0532 | -0.0532 | 1.864B | -10.78% | 1864M |
FQ2 2023 (Apr 2023) | 0.39 | 0.39 | 1.931B | 100% | 1931M |
FQ1 2023 (Jan 2023) | 2.58 | 2.58 | 6.586B | 100% | 6586M |
FQ4 2022 (Oct 2022) | 1.01 | 1.01 | 2.173B | 100% | 2173M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Feb 2027) | 1.022 | -- | 0.9983 | 1.0402 | 8 |
FQ4 2026 (Oct 2026) | 0.398 | -- | 0.39241 | 0.40437 | 6 |
FQ3 2026 (Jul 2026) | -0.03825 | -- | -0.03886265 | -0.03771322 | 3 |
FQ2 2026 (Apr 2026) | 0.0535 | 7221.5 | 0.05274921 | 0.05435691 | 5 |
FQ1 2026 (Jan 2026) | 0.89992 | 28.88 | 0.89992 | 0.89992 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Feb 2027) | 2.33B | -- | 2.29B | 2.36B | 11 |
FQ4 2026 (Oct 2026) | 1.94B | -- | 1.92B | 1.96B | 3 |
FQ3 2026 (Jul 2026) | 1.87B | 0.89 | 1.85B | 1.9B | 3 |
FQ2 2026 (Apr 2026) | 1.82B | 1.59 | 1.8B | 1.85B | 3 |
FQ1 2026 (Jan 2026) | 2.47B | 8.86 | 2.47B | 2.47B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Jul 2025) | 0 | 0 | NAN% | |
FQ2 2025 (May 2025) | -3.81 | -3.81 | 100% | |
FQ1 2025 (Feb 2025) | 0.64 | 0.64 | 100% | |
FQ4 2024 (Nov 2024) | -0.35 | -0.35 | 100% | |
FQ3 2023 (Jul 2023) | -0.0532 | -0.0532 | 100% | |
FQ2 2023 (Apr 2023) | 0.39 | 0.39 | 100% | |
FQ1 2023 (Jan 2023) | 2.58 | 2.58 | 100% | |
FQ4 2022 (Oct 2022) | 1.01 | 1.01 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Jul 2025) | $0B | $1.86B | $1857M | 100% |
FQ2 2025 (May 2025) | $0B | $1.79B | $1794M | 100% |
FQ1 2025 (Feb 2025) | $0B | $2.25B | $2248M | 100% |
FQ4 2024 (Nov 2024) | $0B | $1.96B | $1961M | 100% |
FQ3 2023 (Jul 2023) | $0B | $1.86B | $1864M | 100% |
FQ2 2023 (Apr 2023) | $0B | $1.93B | $1931M | 100% |
FQ1 2023 (Jan 2023) | $0B | $6.59B | $6586M | 100% |
FQ4 2022 (Oct 2022) | $0B | $2.17B | $2173M | 100% |